Regulus Therapeutics Current Ratio 2011-2019 | RGLS

Regulus Therapeutics current ratio from 2011 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Regulus Therapeutics Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2019-09-30 $0.02B $0.02B 0.93
2019-06-30 $0.02B $0.02B 1.19
2019-03-31 $0.02B $0.03B 0.71
2018-12-31 $0.02B $0.03B 0.72
2018-09-30 $0.03B $0.03B 0.99
2018-06-30 $0.04B $0.03B 1.27
2018-03-31 $0.05B $0.03B 1.66
2017-12-31 $0.07B $0.03B 2.05
2017-09-30 $0.08B $0.01B 6.77
2017-06-30 $0.05B $0.01B 4.49
2017-03-31 $0.07B $0.01B 6.40
2016-12-31 $0.09B $0.01B 6.34
2016-09-30 $0.10B $0.01B 7.82
2016-06-30 $0.12B $0.01B 10.47
2016-03-31 $0.12B $0.01B 10.51
2015-12-31 $0.13B $0.01B 10.63
2015-09-30 $0.14B $0.02B 9.24
2015-06-30 $0.14B $0.02B 9.91
2015-03-31 $0.16B $0.01B 11.05
2014-12-31 $0.17B $0.04B 4.69
2014-09-30 $0.10B $0.01B 8.24
2014-06-30 $0.11B $0.01B 9.58
2014-03-31 $0.12B $0.01B 12.36
2013-12-31 $0.12B $0.01B 11.30
2013-09-30 $0.13B $0.01B 9.26
2013-06-30 $0.09B $0.02B 4.57
2013-03-31 $0.09B $0.01B 7.23
2012-12-31 $0.10B $0.01B 7.75
2012-09-30 $0.03B $0.01B 2.56
2012-06-30 $0.00B 0.00
2012-03-31 $0.00B 0.00
2011-12-31 $0.00B 0.00
2011-09-30 $0.00B 0.00
2010-12-31 $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.016B $0.000B
Regulus Therapeutics Inc. is a biopharmaceutical company focused on discovering and developing drugs that target microRNAs, called microRNA therapeutics. The Company's products aim to treat or prevent hepatitis C infections, cardiovascular disease, fibrosis, oncology, immuno-inflammatory diseases, and metabolic diseases. Regulus Therapeutics Inc. is based in La Jolla, California.
Stock Name Country Market Cap PE Ratio
Takeda Pharmaceutical (TAK) Japan $63.153B 9.98
Zoetis (ZTS) United States $57.975B 34.68
Astellas Pharma (ALPMY) Japan $32.884B 16.42
Eisai (ESALY) Japan $21.873B 42.18
Grifols, S.A (GRFS) Spain $15.793B 20.69
UCB SA (UCBJF) Belgium $15.697B 0.00
Merck (MKGAF) Germany $14.809B 20.21
Neurocrine Biosciences (NBIX) United States $10.757B 507.87
Ono Pharmaceutical (OPHLF) Japan $9.450B 20.20
Ionis Pharmaceuticals (IONS) United States $9.088B 18.41
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $8.638B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $8.455B 10.80
IPSEN SA ADR (IPSEY) France $7.796B 0.00
Catalent (CTLT) United States $7.615B 30.98
Arrowhead Pharmaceuticals (ARWR) United States $6.438B 97.49
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.263B 0.00
Orion OYJ (ORINY) Finland $5.849B 30.12
STADA ARZNEIMI (STDAF) Germany $5.375B 0.00
Hypermarcas (HYPMY) Brazil $4.698B 16.89
FibroGen (FGEN) United States $4.135B 121.51
United Therapeutics (UTHR) United States $4.020B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.774B 13.79
Nektar Therapeutics (NKTR) United States $3.598B 0.00
Sage Therapeutics (SAGE) United States $3.340B 0.00
Evotec AG (EVTCY) Germany $3.326B 54.42
PTC Therapeutics (PTCT) United States $3.032B 0.00
Xencor (XNCR) United States $2.329B 70.79
Heron Therapeutics (HRTX) United States $2.318B 0.00
Portola Pharmaceuticals (PTLA) United States $2.273B 0.00
Zogenix (ZGNX) United States $2.074B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.957B 62.40
Pacira Pharmaceuticals (PCRX) United States $1.914B 56.63
Tilray (TLRY) Canada $1.829B 0.00
ChemoCentryx (CCXI) United States $1.816B 0.00
USANA Health Sciences (USNA) United States $1.652B 17.63
Corcept Therapeutics (CORT) United States $1.520B 18.47
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.456B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.264B 28.86
CLINIGEN GP (CLIGF) United Kingdom $1.244B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.197B 0.00
ArQule (ARQL) United States $1.167B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.112B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.101B 7.51
Endo (ENDP) Ireland $1.098B 2.02
Karyopharm Therapeutics (KPTI) United States $1.023B 0.00
Radius Health (RDUS) United States $1.012B 0.00
Aerie Pharmaceuticals (AERI) United States $0.920B 0.00
Flexion Therapeutics (FLXN) United States $0.746B 0.00
Collegium Pharmaceutical (COLL) United States $0.706B 0.00
Akebia Therapeutics (AKBA) United States $0.703B 0.00
TherapeuticsMD (TXMD) United States $0.659B 0.00
Translate Bio (TBIO) United States $0.600B 0.00
ImmunoGen (IMGN) United States $0.579B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.493B 0.00
Organogenesis Holdings (ORGO) United States $0.484B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.481B 58.38
Harpoon Therapeutics (HARP) United States $0.466B 0.00
Molecular Templates (MTEM) United States $0.452B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.440B 0.00
Ardelyx (ARDX) United States $0.430B 0.00
Dermira (DERM) United States $0.430B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.406B 17.52
BioCryst Pharmaceuticals (BCRX) United States $0.396B 0.00
Indivior (INVVY) United States $0.385B 1.39
DURECT (DRRX) United States $0.377B 0.00
Recro Pharma (REPH) United States $0.375B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.364B 0.00
Siga Technologies (SIGA) United States $0.359B 8.20
Innate Pharma SA (IPHYF) France $0.358B 0.00
Lannett Co Inc (LCI) United States $0.355B 4.13
OptiNose (OPTN) United States $0.352B 0.00
Concordia (CXRXF) Canada $0.333B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.332B 0.00
Rafael Holdings (RFL) United States $0.318B 0.00
GlycoMimetics (GLYC) United States $0.260B 0.00
Jounce Therapeutics (JNCE) United States $0.259B 3.46
KalVista Pharmaceuticals (KALV) United States $0.256B 0.00
Calithera Biosciences (CALA) United States $0.252B 0.00
Xeris Pharmaceuticals (XERS) United States $0.236B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.236B 0.00
Ocular Therapeutix (OCUL) United States $0.210B 0.00
Aquestive Therapeutics (AQST) United States $0.201B 0.00
Nature's Sunshine Products (NATR) United States $0.189B 32.57
Foamix Pharmaceuticals (FOMX) Israel $0.187B 0.00
Concert Pharmaceuticals (CNCE) United States $0.175B 0.00
Taiwan Liposome (TLC) Taiwan $0.161B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.149B 0.00
MEI Pharma (MEIP) United States $0.144B 0.00
Redhill Biopharma (RDHL) Israel $0.144B 0.00
IMV INC (IMV) Canada $0.143B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.141B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.137B 0.00
CannTrust Holdings (CTST) Canada $0.119B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Champions Oncology (CSBR) United States $0.091B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.089B 0.00
CV Sciences (CVSI) United States $0.085B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.078B 23.45
MediWound (MDWD) Israel $0.078B 0.00
Otonomy (OTIC) United States $0.077B 0.00
PolarityTE (PTE) United States $0.076B 0.00
Neos Therapeutics (NEOS) United States $0.073B 0.00
Infinity Pharmaceuticals (INFI) United States $0.071B 0.00
Capnia (SLNO) United States $0.070B 0.00
Aclaris Therapeutics (ACRS) United States $0.069B 0.00
Cardiome Pharma (CORV) Canada $0.066B 0.00
Pharmaxis (PXSLY) Australia $0.065B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.065B 0.00
RENEURON GP (RNUGF) United Kingdom $0.062B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.058B 0.00
Novan (NOVN) United States $0.057B 0.00
Nivalis Therapeutics (ALPN) United States $0.057B 0.00
Genocea Biosciences (GNCA) United States $0.056B 0.00
SCYNEXIS (SCYX) United States $0.056B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.055B 0.00
Natural Alternatives (NAII) United States $0.055B 13.73
CTI BioPharma (CTIC) United States $0.054B 0.00
Medicure (MCUJF) Canada $0.054B 0.00
IntelGenx Technologies (IGXT) Canada $0.051B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.049B 0.00
ElectroCore (ECOR) United States $0.049B 0.00
Mast Therapeutics (SVRA) United States $0.046B 0.00
Iterum Therapeutics (ITRM) Ireland $0.046B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.041B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.040B 0.00
Mannatechorporated (MTEX) United States $0.038B 0.00
Opexa Therapeutics (ACER) United States $0.037B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.034B 0.00
Jaguar Animal Health (JAGX) United States $0.030B 0.00
PharmAthene (ALT) United States $0.029B 0.00
Biomerica (BMRA) United States $0.028B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.025B 0.00
ProPhase Labs (PRPH) United States $0.024B 0.00
Melinta Therapeutics (MLNT) United States $0.024B 0.00
Bio-Path Holdings (BPTH) United States $0.023B 0.00
Shineco (TYHT) China $0.021B 0.00
China SXT Pharmaceuticals (SXTC) China $0.020B 0.00
Flex Pharma (SLRX) United States $0.016B 0.00
Vical (BBI) United States $0.016B 0.00
Heat Biologics (HTBX) United States $0.015B 0.00
VAXART, INC (VXRT) United States $0.015B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.014B 0.00
Cyanotech (CYAN) United States $0.014B 0.00
Lipocine (LPCN) United States $0.010B 0.00
HANCOCK JAFFE (HJLI) United States $0.009B 0.00
Achieve Life Sciences (ACHV) United States $0.008B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
RXi Pharmaceuticals (PHIO) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Onconova Therapeutics (ONTX) United States $0.002B 0.00
Midatech Pharma (MTP) United Kingdom $0.002B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.001B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00
Forward Pharma (FWP) Denmark $0.000B 0.00